EMBODVY Trademark

Trademark Overview

On Wednesday, September 10, 2025, a trademark application was filed for EMBODVY with the United States Patent and Trademark Office. The USPTO has given the EMBODVY trademark a serial number of 79436819. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 7, 2026. This trademark is owned by MoonLake Immunotherapeutics AG. The EMBODVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment and prevention of inflammatory and immunological diseases and disorders
embodvy

General Information

Serial Number79436819
Word MarkEMBODVY
Filing DateWednesday, September 10, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment and prevention of inflammatory and immunological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 13, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMoonLake Immunotherapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameMoonLake Immunotherapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, November 13, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, November 19, 2025ASSIGNED TO EXAMINER
Wednesday, November 19, 2025NON-FINAL ACTION WRITTEN
Thursday, November 20, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, January 4, 2026REFUSAL PROCESSED BY MPU
Sunday, January 4, 2026NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 22, 2026REFUSAL PROCESSED BY IB
Friday, March 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 13, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 13, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 13, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 13, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 13, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, March 13, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 16, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 7, 2026PUBLISHED FOR OPPOSITION
Tuesday, April 7, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

embodvy immunological diseases disorders inflammatory prevention preparations substances treatment pharmaceutical